Litcius/Paper detail

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial

Xing Lv, Xun Cao, Wei‐Xiong Xia, Kui‐Yuan Liu, Meng‐Yun Qiang, Ling Guo, Chao‐Nan Qian, Ka–Jia Cao, Hao‐Yuan Mo, Xianming Li, Zihuang Li, Fei Han, Yuxiang He, Yumeng Liu, Shaoxiong Wu, Yongrui Bai, Liang‐Ru Ke, Wen‐Ze Qiu, Hu L, Guoying Liu, Jingjing Miao, Wang‐Zhong Li, Shu‐Hui Lv, Xi Chen, Chong Zhao, Yan‐Qun Xiang, Xiang Guo

2021The Lancet Oncology83 citationsDOI

Topics & Concepts

Nasopharyngeal carcinomaCisplatinMedicineRegimenFluorouracilInduction chemotherapyChemoradiotherapyInternal medicineChemotherapyRadiation therapyOncologyGastroenterologyHead and Neck Cancer StudiesHead and Neck Surgical OncologyAdvanced Drug Delivery Systems